Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
-
Narrated by:
-
By:
About this listen
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
- Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet